• Home
  • Curriculum
  • Research
  • Selected Publications
  • Full Publication List
  • Doctoral Thesis
  • Group Members
  • Gallery
  • Support
  • News
  • Positions
  • Contact us
  • GI-2155

Targeting Infectious Diseases

Our main research interest is to develop updated therapies targeting infectious diseases, in particular, drugs with new mechanisms of action to combat the growth of antibiotic-resistant bacteria.

One of the strategies for the development of new antibiotics is to design compounds capable of interfering with essential processes for the survival of the bacteria. This possibility has been studied in our research group in the last few years. It consists in the design and the synthesis of compounds whose mode of action is based on the selective and the effective inhibition of two essential enzymes of the shikimic acid pathway (Scheme 1), dehydroquinase (aroD/aroQ gene) and shikimate kinase (aroK gene).

Particularly, we have been focusing in two important pathogens, Mycobacterium tuberculosis, the bacterium that causes tuberculosis and Helicobacter pylori, the causative agent of gastric and duodenal ulcer and it has also been classified as type I carcinogen.

Scheme 1. The Shikimic Acid Pathway
Scheme 1. The Shikimic Acid Pathway
  • Type II Dehydroquinase
  • Type I Dehydroquinase
  • Shikimate kinase
  • Structural Studies
  • Molecular Modeling Studies
www.usc.es/ciqus/


Centro Singular de Investigación

en Química Biolóxica e

Materiais Moleculares (CIQUS)

Universidade de Santiago de Compostela (USC)

Santiago de Compostela

Spain

 

 

 

Aviso legal | Política de privacidad | Mapa del sitio
Salir | Editar
  • Home
  • Curriculum
  • Research
    • Type II Dehydroquinase
    • Type I Dehydroquinase
    • Shikimate kinase
    • Structural Studies
    • Molecular Modeling Studies
  • Selected Publications
  • Full Publication List
  • Doctoral Thesis
  • Group Members
  • Gallery
  • Support
  • News
  • Positions
  • Contact us
  • GI-2155